Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Feb 9:2:85-88.
doi: 10.1016/j.ymgmr.2015.01.002. eCollection 2015 Mar.

When should social service referral be considered in phenylketonuria?

Affiliations
Case Reports

When should social service referral be considered in phenylketonuria?

Margreet van Rijn et al. Mol Genet Metab Rep. .

Abstract

Lifelong low-phenylalanine (Phe) dietary management is the foundation of care in phenylketonuria (PKU). However, strict monitoring of food intake places a burden on patients and their caregivers, and adherence to the required diet frequently decreases in later childhood and adolescence. Rarely, parents of children with PKU refuse to recognise the importance of treatment and follow-up for this chronic condition. Here, two case studies are presented that document consideration of placement of children into foster care or kinship homes as a last resort to improve persistently high Phe concentrations. In the first case, social service referral led to a 3-year-old girl being placed in a kinship home with her grandparents, resulting in excellent Phe control thereafter. In the second case, discussion with the parents of possible placement of a 12-year-old child into foster care was sufficient to have a positive effect on Phe control. A staged approach for managing intractable non-adherence in PKU is proposed.

Keywords: Adherence; Case study; Child protection; Foster care; HCPs, healthcare professionals; PKU, phenylketonuria.; Phe, phenylalanine; Phenylketonuria; Social services.

PubMed Disclaimer

References

    1. Ahring K., Belanger-Quintana A., Dokoupil K., Gokmen-Ozel H., Lammardo A.M., MacDonald A., Motzfeldt K., Nowacka M., Robert M., van R.M. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres. Eur. J. Clin. Nutr. 2011;65:275–278. - PubMed
    1. Crone M.R., van Spronsen F.J., Oudshoorn K., Bekhof J., van R.G., Verkerk P.H. Behavioural factors related to metabolic control in patients with phenylketonuria. J. Inherit. Metab. Dis. 2005;28:627–637. - PubMed
    1. Mundy H., Lilburn M., Cousins A., Lee P. Dietary control of phenylketonuria. Lancet. 2002;360:2076. - PubMed
    1. Walter J.H., White F.J., Hall S.K., MacDonald A., Rylance G., Boneh A., Francis D.E., Shortland G.J., Schmidt M., Vail A. How practical are recommendations for dietary control in phenylketonuria? Lancet. 2002;360:55–57. - PubMed
    1. Waisbren S.E., Noel K., Fahrbach K., Cella C., Frame D., Dorenbaum A., Levy H. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol. Genet. Metab. 2007;92:63–70. - PubMed

Publication types